Ringler; Douglas J.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Ringler; Douglas J..The latest application filed is for "human chemotactic cytokine".
- Ringler; Douglas J. - Revere MA
- Ringler, Douglas J. - Cambridge MA
| Patent | Date |
|---|---|
| Method of diagnosis of inflammatory disease using eotaxin antibodies Grant 7,858,326 - Ponath , et al. December 28, 2 | 2010-12-28 |
| Mucosal vascular addressing and uses thereof Grant 7,803,904 - Briskin , et al. September 28, 2 | 2010-09-28 |
| Human chemotactic cytokine App 20090110659 - Ponath; Paul D. ; et al. | 2009-04-30 |
| Humanized immunoglubulin reactive with alph4beta7 integrin App 20090011464 - Ponath; Paul D. ; et al. | 2009-01-08 |
| Antibodies to human eotaxin Grant 7,423,129 - Ponath , et al. September 9, 2 | 2008-09-09 |
| Humanized immunoglobulin reactive with .alpha.4.beta.7 integrin Grant 7,402,410 - Ponath , et al. July 22, 2 | 2008-07-22 |
| Human chemotactic cytokine App 20080070300 - Ponath; Paul D. ; et al. | 2008-03-20 |
| Human chemotactic cytokine Grant 7,285,620 - Ponath , et al. October 23, 2 | 2007-10-23 |
| Human chemotactic cytokine Grant 7,265,201 - Ponath , et al. September 4, 2 | 2007-09-04 |
| Mucosal vascular addressins and uses thereof App 20070178089 - Briskin; Michael J. ; et al. | 2007-08-02 |
| Humanized immunoglobulin reactive with alpha4beta7 integrin App 20060292140 - Ponath; Paul D. ; et al. | 2006-12-28 |
| Humanized immunoglobulin reactive with .alpha.4.beta.7 integrin Grant 7,147,851 - Ponath , et al. December 12, 2 | 2006-12-12 |
| Human chemotactic cytokine App 20060141567 - Ponath; Paul D. ; et al. | 2006-06-29 |
| Mucosal vascular addressins and uses thereof App 20060057135 - Briskin; Michael J. ; et al. | 2006-03-16 |
| Inducing tolerance in primates App 20040175381 - Winsor-Hines, Dawn ; et al. | 2004-09-09 |
| Treatment of Inflammatory bowel disease by inhibiting binding and/or signalling through .alpha. 4 .beta. 7 and its ligands and madcam Grant 6,551,593 - Ringler , et al. April 22, 2 | 2003-04-22 |
| Treatment of inflammatory bowel disease by inhibiting binding and/or signalling through alpha4beta7 and its ligands and MAdCAM App 20020172679 - Ringler, Douglas J. ; et al. | 2002-11-21 |
| Mucosal Vascular Addressins And Uses Thereof App 20020147314 - BRISKIN, MICHAEL J. ; et al. | 2002-10-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 